市場調査レポート

世界の分子診断市場:半期アップデート

The World Market for Molecular Diagnostics Update: Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics & CTCs

発行 Kalorama Information 商品コード 294566
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
世界の分子診断市場:半期アップデート The World Market for Molecular Diagnostics Update: Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics & CTCs
出版日: 2014年01月14日 ページ情報: 英文 80 Pages
概要

分子診断市場は臨床医学における有力なプラットフォームになりつつあり、診断市場の急成長セグメントのひとつです。多くの分子検査がCEマーク・FDA認定を獲得しており、さらに多くの検査が開発中です。しかし、より多くの独自検査が特に癌管理・感染症伝染病学において検査サービスとして発売されています。

当レポートでは、過去6ヵ月間に重点を置いて、世界の分子診断市場における検査開発活動および規制・医療費償還の課題について調査し、分子診断セグメント別の現在の市場規模および予測などをまとめ、概略下記の構成でお届けいたします。

第1章 市場概要

第2章 シーケンシングはクリニックに移行

  • 背景
  • 癌はより個人的に
  • 病原菌シーケンシング

第3章 癌における血液ベースのマーカー市場

  • 背景
  • 血液ベースの分析
  • 循環腫瘍細胞(CTC)

第4章 血液学における分子アッセイ市場

  • 背景

第5章 凝析・心疾患治療における分子アッセイ市場

  • 背景
  • 凝析市場の分析

第6章 組織病理学/細胞学における分子アッセイ市場

  • 背景
  • 分子組織学
  • 市場分析
  • HPV検査

第7章 微生物学/ウィルス学における分子アッセイ市場

  • 概要
  • HIV/AIDS
  • 肝炎
  • 性感染症
  • 院内感染
  • 呼吸器感染症
  • 結核
  • 血液培養
  • 質量分析

第8章 輸血スクリーニングにおける分子アッセイ市場

  • 背景
  • 血液病原菌スクリーニング
  • 血液型判定

第9章 輸血スクリーニングにおける分子アッセイ市場

  • 背景
  • 血液病原菌スクリーニング
  • 血液型判定

第10章 遺伝病におけるにおける分子アッセイ市場

  • 市場分析

第11章 臓器移植における分子アッセイ市場

  • マネジメント
  • 市場分析

第12章 分子アッセイ市場

  • 出生前診断・新生児診断
  • 市場分析

第13章 今後6ヵ月間の展望

  • 2014年1-6月
  • 市場分析

図表

目次
Product Code: KLI5181507

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July - December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.

Though focused on the developments of the last six months, coverage is substantial. As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

  • Microbiology
  • Histology
  • Blood Screening
  • Prenatal
  • Coagulation
  • Inherited Diseases
  • Tissue Typing
  • Cancer Markers
  • Pharmacodiagnostics
  • CTCs

The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.

In addition the following important trend information is also provided:

  • Selected Sequencing-Based Innovations July-December 2013
  • Selected Molecular Diagnostics Collaborations, July-December 2013
  • Selected Molecular Diagnostics Licensing Agreements, July-December 2013
  • Selected Molecular Diagnostics Distribution Agreements, July-December 2013
  • Regulatory and Reimbursement Update
  • Molecular Test Revenues of The Top Companies, 2012-2013

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.

Table of Contents

CHAPTER ONE: MARKET OVERVIEW

  • Background
  • Scope and Methodology
  • Size And Growth Of The Market, Worldwide
  • Regulatory and Reimbursement Update
  • Company Moves
  • Top Suppliers and Niche players
  • Test Services Continue to Expand
  • Point of View

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC

  • Background
  • Cancer gets more personal
  • Pathogen sequencing

CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER

  • Background
  • Blood-based analyses
  • Circulating Tumor Cells

CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY

  • Background

CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE

  • Background
  • Coagulation Market Analysis

CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY

  • Background
  • Molecular Histology
  • Market Analysis
  • HPV Testing

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY

  • Overview
  • HIV/AIDS
  • Hepatitis
  • Sexually Transmitted Diseases
  • Hospital Acquired Infections
  • Respiratory Tract Infections
  • Tuberculosis
  • Blood Culture
  • Miscellaneous
  • Mass Spectrometry

CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING

  • Background
  • Blood Pathogen Screening
  • Blood Typing

CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING

  • Background
  • Blood Pathogen Screening
  • Blood Typing

CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases

  • Market Analysis

CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant

  • Management
  • Market Analysis

CHAPTER TWELVE: The Market For Molecular Assays

  • In Prenatal And Neonatal Testing
  • Market Analysis

CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months

  • January To June 2014
  • Market Analysis

CHAPTER ONE: MARKET OVERVIEW

  • Table 1-1: Exchange Rate Fluctuations, 2009-2013
  • Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
  • Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
  • Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
  • Table 1-4: Selected Advanced Test Innovations, July - December 2013
  • Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013
  • Table 1-6: Selected collaborations, July-December 2013
  • Table 1-7: Selected licensing agreements, July-December 2013
  • Table 1-8: Selected distribution agreements, July-December 2013
  • Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013
  • Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013
  • Table 1-10: Selected Molecular Test Services, Sales 2012-2013
  • Table 1-11: Selected Molecular Test Services, July-December 2013

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC

  • Table 2-1: Major Sequencing Platforms
  • Table 2-2: Selected Sequencing-Based Innovations July-December 2013

CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER

  • Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013
  • Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013
  • Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013

CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY

  • Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013

CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE

  • Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013

CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY

  • Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013
  • Table 6-2: Selected Molecular Histology Innovations, July-December 2013
  • Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July - December 2013
  • Table 6-4: Selected Innovations In HPV Testing, July -December 2013

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY

  • Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013
  • Table 7-2: Selected Hepatitis Test Innovations, July-December 2013
  • Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013
  • Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013
  • Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013
  • Table 7-6: Selected Microbiology Innovations, July-December 2013

CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES

  • Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July - December 2013

CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management

  • Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013
Back to Top